• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Evaluation of Disease Activity and Abnormal Immune Response in Systemic Lupus Erythematosus by Active Oxygen Lymphocytes

Research Project

Project/Area Number 08672645
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionKUMAMOTO UNIVERSITY

Principal Investigator

ISHII Toshinori  KUMAMOTO UNIVERSITY,COLLEGE OF MEDICAL SCIENCE,ASSISTANT PROFESSOR, 医療技術短期大学部, 助教授 (30093983)

Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1997: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1996: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsLymphocytes / Superoxides / Lupus Erythematosus / Apoptosis / Fas / bcl-2 / Cell Adhesion Molecules / Cytokiones / Flow Cytometry / Monocytes
Research Abstract

1.All of peripheral blood lympocyte (PBL) subsets showed productivity of active oxygen (AO) as they responded to stimulation with phorbor myristate acetate (PMA) .
2.PBLs of systemic jupus erythematosus (SLE) patients produced more AO than ones of healthy persons.Tha cause of high AO production in SLE is speculated as lymphocytes are stimulated with plasma cytokines, for ex-ample IL-lbeta, TNF-alfa and IFN-gamma, and/or cell adhesion molecules such as CDlla and CD29.
3.Amount of AO was correlated positivery with apoptosis rate and negatively with the number of PBLs.And PBLs of healthy persons stimulated with various stimulants due to raising AO production tended to fall into apoptosis.Therefore depletion of PBLs in SLE is suggested to be caused by apoptosis triggered with AO.
4.Fas antigen (CD95) expression was augmented and correlated positively with AO in all PBL subsets of SLE.And bcl-2 expression was also augmented in SLE.SO I suppose that many PBLs in SEL have apoptosis sensitive property and that induction of real apoptosis depends on quantity of bcl-2.In other worts jow bcl-2 PBLs were removed by apoptosis in vivo, and I measured residual high bcl-2 PBLs.
5.When PBLs were cultured with anti-CD3 antibody and anti-Fas antibody, PBLs in SLE expressed more in Fas antigen and less in bcl-2 antigen and apoptosis than in hsalthy persons.This result suggests that there are apoptosis resistant PBLs in SLE.
6.Measurement of AO in PBLs is not suitable for evaluation of disease activity in SLE because of no correlation of AO with almost all clinical manifestations and laboratory data but could be indicator of lesistance to SLE because of negative correlation of AO with anti-DNA antibody.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] 石井 俊徳: "全身性エリテマトーデスの臓器障害と白血球抗原、白血球活性酸素、血漿サイトカインとの関係" 熊本大学医療技術短期大学部紀要. 第7号. 33-40 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 石井 俊徳: "リンパ球の活性酸素産生" 熊本大学医療技術短期大学部紀要. 第8号. 63-73 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Toshinori Ishii: "Relationship of Disorders in Systemic Lupus Erythematosus to Leukocyte Surface Antigens, Leukocyte Active Oxygen and Plasma Cytokines." Bulletion of Kumamoto University College of Medical Science. The 7th Issue. 33-40 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Toshinori Ishii: "Reactive Oxygen Species Produc-tion by Lymphocytes" Bulletin of Kumamoto University College of Medical Science. The 8th Issue. 62-73 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 石井,俊徳: "全身性エリテマトーデスの臓器障害と白血球抗原、白血球活性酸素、血漿サイトカインとの関係" 熊本大学医療技術短期大学部紀要. 第7号. 33-40 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi